A fter myocardial infarction (MI), the left ventricle (LV) undergoes molecular, cellular, and extracellular matrix (ECM) changes that dramatically alter the size, shape, and function at the organ level.
February 15, 2013
proprotein convertase activates the 58-kDa proform of MMP-28 to its 48-kDa active form, which is then secreted into the ECM environment. 13 In vitro, MMP-28 has been shown to proteolytically process casein, Nogo-A (a myelin component), and neural cell adhesion molecule-1.
12,14 MMP-28 is highly expressed in many normal adult tissues and organs, including the heart, suggesting roles in normal tissue homeostasis. MMP-28 expression is upregulated in cancers, multiple sclerosis, and cardiac aging. 15, 16 MMP-28 promotes transforming growth factor (TGF)-β-triggered epithelial to mesenchymal transition in lung carcinoma cells. 17 MMP-28 deletion also increases macrophage infiltration to the lung during pneumonia and facilitates airway epithelial cell apoptosis induced by influenza challenge, suggesting protective roles after injury. 18, 19 Our previous study showed that MMP-28 deletion augmented the inflammatory and ECM responses to cardiac aging. 15 However, the functional significance of MMP-28 post-MI remains to be elucidated. Accordingly, the objective of this study was to determine the impact of MMP-28 deletion on MI-induced LV remodeling and dysfunction. We hypothesized that MMP-28 deletion would exacerbate post-MI LV remodeling and dysfunction by modulating inflammatory and ECM responses. We used the permanent occlusion model in this study to induce a robust remodeling response, to dissect the potential molecular mechanisms in a model that has a large effect size. 20 Of note, ≈20% of MI patients are actually not reperfused, translating to ≈250 000 patients each year in the United States that have permanent occlusion MIs. 21 
Methods
Detailed descriptions of the materials and methods are available in the Online Data Supplement. The experimental design is given in Online Table I . A brief description of the methods used is given below.
Mice
All animal procedures were performed following the Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at the University of Texas Health Science Center at San Antonio. Adult C57BL/6J wild-type (WT; n=76) and −/− (n=86) mice of both sexes were used in this study.
MI Surgery
MI was induced by permanent occlusion of the left coronary artery, as previously described.
22,23
Echocardiography LV function was evaluated by using the Vevo 770 system (VisualSonics) as previously described. 15 The LV remodeling index was calculated as the ratio of end-diastolic volume to LV mass. 23 
Survival Analysis and Autopsy
The mice were checked daily for survival. Cardiac rupture was confirmed by autopsy.
Tissue Harvest and Infarct Area Evaluation
The heart was collected as described previously. 15 The LV infarct region (LVI) was separated from the remote region (LVC). Infarct area was calculated as the percentage of infarct area to total LV area. 23 The edema index was calculated as lung weight:tibia length ratio.
Immunoblotting
Immunoblotting was performed as described previously. 15 ImageJ was used to measure densitometry, and the total protein was used as the internal loading control for each lane.
Immunofluorescence
Immunofluorescence was performed as described previously. 24 Colocalization was performed using either an antibody for MMP-28 and phalloidin or antibodies for MMP-28 and Mac-3 to determine the cellular localization of MMP-28. The α-smooth muscle actin (SMA) antibody was used to visualize myofibroblasts.
Plasma Proteomic Profiling
Plasma proteomic profiling of 58 analytes were measured as described previously. 
Real-Time RT

-Polymerase Chain Reaction (PCR)
Real Time RT 2 -PCR gene array for inflammatory cytokines and receptors (Qiagen, PAMM-011A) and for ECM and adhesion molecules (Qiagen, PAMM-013A) were performed to quantify gene expression levels. 15 Gene levels were normalized to the reference gene hprt1, and the data are reported as 2 -△C t values×100±SEM.
Immunohistochemistry
As described previously, macrophage staining was performed by using a specific antibody against Mac-3, and the percentage of positively stained area to total area was quantified.
Statistical Analyses
Data are presented as mean±SEM. Two group comparisons were analyzed by unpaired t test. Multiple group comparisons were performed using the 1-way ANOVA, followed by the StudentNewman-Keuls posttest (when the Bartlett variation test passed), or using the nonparametric Kruskal-Wallis test followed by Dunn posttest (when the Bartlett variation test did not pass). 
Results
MMP-28 Cell Source Post-MI Shifted From the Myocyte to the Macrophage
Previous studies report that MMP-28 is expressed in adult mouse hearts, and we confirmed high expression pre-MI ( Figure 1A) . 15, 16 Post-MI, total MMP-28 levels were significantly decreased in both remote and infarct areas. In the LVC, the decrease was not seen until the day 7 post-MI time point; however, in the LVI, MMP-28 expression was reduced at days 3, 5, and 7 post-MI. The decrease in MMP-28 was consistent with the pattern of cardiomyocyte loss.
We investigated the cellular source of MMP-28 by dual immunofluorescence staining. At day 0 pre-MI, MMP-28 colocalized with the myocyte marker phalloidin ( Figure 1B ), indicating that cardiomyocytes are a major source of MMP-28 under the normal setting. In agreement with a previous study showing that macrophages can secrete MMP-28, MMP-28 colocalized with Mac-3 ( Figure 1C ), a marker of macrophages, after MI. 18 These findings indicate that myocyte-derived MMP-28 decreases, whereas macrophage-derived MMP-28 increases post-MI.
MMP-28 Deletion Decreased Survival and Increased Cardiac Rupture Rates
Infarct areas were similar between WT and MMP-28 −/− mice for all time points examined (Figure 2A ), demonstrating that MMP-28 deficiency had no effect on the acute ischemia response. We attempted to perform a 28-day post-MI survival analysis, but all male MMP-28 −/− mice with MI died before day 28. For this reason, we performed a 7-day post-MI survival rate analysis. As shown in Figure 2B, Figure 2C ). We did not observe any difference in rupture time kinetics between the 2 genotypes. Cardiac rupture primarily occurred between 3 and 7 days post-MI, consistent with previous reports. 26, 27 
MMP-28 Deletion Deteriorated Post-MI LV Function
As expected, the LV end-systolic and end-diastolic volumes increased in WT mice post-MI ( Figure 2D and 2E) . Interestingly, the decrease in ejection fraction at day 1 post-MI was attenuated in the absence of MMP-28, compared with WT ( Figure 2F ; P<0.05), indicating that cardiac function was actually better at day 1 when MMP-28 was absent. By day 7, the end-systolic and end-diastolic volumes in MMP-28 −/− mice were 31% and 25% higher, respectively, compared with WT (both P<0.05). The increases in volumes translated to a reduced ejection fraction with MMP-28 deletion, compared with day 7 post-MI WT (P<0.05). These data suggest that MMP-28 deletion improves the early cardiac functional response, whereas exacerbating Post-MI, pump dysfunction leads to increased LV end-diastolic pressure and subsequent pulmonary edema. In Figure  2G , lung weight:tibia length (edema index) ratio markedly increased at days 5 and 7 post-MI in both WT and MMP-28 −/− mice, compared with day 0 controls (all P<0.05). The edema index was 22% higher in MMP-28 −/− mice, compared with WT at day 7 post-MI (P<0.05), indicating worse lung edema.
The ratio of end-diastolic volume to LV mass represents the LV remodeling index that increases during cardiac remodeling and repair. 23 Our data demonstrated that the LV remodeling index progressively increased from days 0 to 7 post-MI in WT mice ( Figure 2H ; all P<0.05 versus day 0). MMP-28 −/− mice showed similar increases in LV remodeling index at days 1, 3, and 5 post-MI but displayed a 20% higher remodeling index at day 7 post-MI than WT mice ( Figure 2H ; P<0.05), indicating that adverse LV remodeling was accentuated.
MMP-28 Deletion Did Not Influence Tumor Necrosis Factor (TNF)-α Level in Plasma and LV at Day 1
TNF-α is involved in the pathogenesis and progression of MI, ischemia/reperfusion, and heart failure. [28] [29] [30] Plasma TNF-α levels increased at day 1 in WT and MMP-28 −/− mice (both P<0.05 versus day 0), and returned toward baseline by day 7 post-MI (Online Figure IA) . In the LV, TNF-α mRNA content was not significantly upregulated in either group, compared with respective day 0 levels (Online Figure IB) .
Post-MI Plasma Proteomic Profiling
To determine the impact of MMP-28 deletion on plasma biomarkers, we conducted plasma proteomic profiling of 58 analytes (Table 1; Online Table II) . The 13 analytes shown in Table 1 were significantly upregulated at day 7 post-MI in WT mice, as expected for an MI response. In the WT group, basic fibroblast growth factor was the only factor decreased at day 7 post-MI (P<0.05 versus day 0). In the MMP-28 −/− mice, 10 analytes were statistically increased at day 7 after MI (all P<0.05), all of which overlapped with analytes increased in WT. These factors, therefore, are MI but not MMP-28 dependent. The 3 factors that did not increase in MMP-28 −/− mice were Factor VII, fibrinogen, and MMP-9, suggesting these 3 may be downstream signaling effectors of MMP-28. Basic fibroblast growth factor was downregulated in MMP-28 −/− mice similar to WT, and macrophage-derived chemokine was also decreased, compared with day 0 controls (both P<0.05).
Interestingly, at day 7 post-MI, 4 analytes in the MMP-28 −/− mice were higher than WT MI counterparts (endothelin-1, macrophage inflammatory protein-1β, myeloperoxidase, and thrombopoietin, all P<0.05).
Reduced Inflammatory Factors in the MMP-28 −/− Mice
The inflammatory response regulates post-MI LV remodeling. For this reason, we explored the effect of MMP-28 deletion on inflammation by examining gene levels of 84 inflammatory cytokines and receptors (Table 2 ; Online Table III) . At day 7 post-MI, 36 genes were significantly upregulated and 7 genes were downregulated in the LVI of WT day 7 MI mice, compared with day 0 (all P<0.05); whereas 25 genes in the LVI of MMP-28 −/− mice were statistically increased by MI, and 9 decreased, compared with day 0 (all P<0.05). These changes were consistent with a robust inflammatory response in the LVI. In the remote area of day 7 post-MI WT mice, the expression of 10 genes was increased and 5 decreased, compared with day 0 (all P<0.05). Only 3 genes in the LVC of MMP-28 −/− mice were upregulated, and 11 downregulated compared with day 0 (all P<0.05).
When compared with WT day 7 MI, 16 genes in the LVI and 4 genes in the LVC were lower in the MMP-28 −/− mice (all P<0.05), indicating an overall decreased inflammatory response in the absence of MMP-28.
M2 Macrophage Polarization Was Impaired by MMP-28 Deletion
Macrophages are a major source of inflammatory factors post-MI. Therefore, we explored the impact of MMP-28 deletion on macrophage infiltration and phenotype. The expression of galectin-3, a macrophage marker, was induced in WT infarct LV at day 3 and peaked at day 5 post-MI ( Figure  3A ; P<0.05 versus day 3), consistent with our previously published time course.
7 MMP-28 −/− mice showed similar increases in macrophage content in the post-MI LVI, compared with WT counterparts at the same time points ( Figure 3A) . Immunohistochemistry staining for Mac-3 also demonstrated similar macrophage infiltration rates at day 5 post-MI in WT and MMP-28 −/− mice ( Figure 3B ). Macrophage infiltration, therefore, was not altered by MMP-28 deletion. Proinflammatory M1 macrophages promote ECM degradation, whereas anti-inflammatory M2 macrophages facilitate the ECM reconstruction and reparative response. Our quantitative real-time PCR data showed that at day 7 post-MI, IL-1β was the only M1 marker reduced with MMP-28 deletion ( Figure  3C ). Of the M2 markers measured, all except Ym1 were significantly reduced in the absence of MMP-28 ( Figure 3D ). These results suggest that M2 macrophage activation was compromised in the MMP-28 −/− infarct. To further investigate the impact of MMP-28 deletion on macrophage phenotype, peritoneal macrophages isolated from WT and MMP-28 −/− mice were stimulated with IFN-γ+LPS or IL-4. MMP-28 expression in macrophages was not altered after stimulation with IFN-γ+LPS or IL-4 ( Figure  4A ), suggesting that distinct macrophage phenotypes have no difference in MMP-28 expression. All M1 markers measured here showed similar upregulation in both WT and MMP- (Table 2; Online  Table IV ). In the infarct area of WT, 51 genes increased and 8 genes decreased, compared with day 0 (all P<0.05). In Figure 5A ; P<0.05). In contrast to WT, the collagen III content at day 7 post-MI was 26% lower in MMP-28 −/− mice ( Figure 5B; 
P<0.05).
Lysyl oxidase is a copper-dependent extracellular enzyme that mediates cross-linking in collagen and elastin. 33, 34 Our immunoblotting data revealed that in the WT, both the precursor (50 kDa) and active (32 kDa) forms were gradually upregulated from days 3 to 7 post-MI ( Figure 5C ; both P<0.05). However, in the MMP-28 −/− mice, both forms of lysyl oxidase were partially inhibited by MMP-28 deletion ( Figure 5C ; both P<0.05). At day 7 post-MI, there was notable inhibition of the active form. Lysyl oxidase catalyzes the telopeptidyl hydroxylysyl residues to form hydroxylysyl pyridinoline and lysyl pyridinoline, which are directly involved in the collagen cross-linking. 35 The day 7 LVIs in MMP-28 −/− mice had reduced hydroxylysyl pyridinoline and lysyl pyridinoline, compared with WT (Figure 5D and 5E; both P<0.05) . MMP-28 deletion, therefore, suppressed collagen synthesis and 
Myofibroblast Numbers Were Lower in the MMP-28 −/− Mice
After MI, fibroblasts transdifferentiate into myofibroblasts that express α-SMA. Furthermore, myofibroblasts are a primary source of ECM in the infarcted myocardium. To explore whether decreased ECM synthesis in MMP-28 −/− mice was the result of reduced myofibroblast numbers, we measured myofibroblast content in the infarct hearts. As displayed in Figure 6A , α-SMA was highly expressed in the LVIs of both WT and MMP-28 −/− mice. At days 3 and 5 post-MI, there were no significant differences between the 2 genotypes. However, α-SMA levels at day 7 were markedly lower in MMP-28 −/− mice than WT ( Figure  6A ; P<0.05). Immunofluorescence staining confirmed reduced α-SMA-positive myofibroblast numbers in the nonvessel interstitium of the LVI in MMP-28 −/− mice at day 7 post-MI ( Figure 6B ).
MMP-28 Deletion Affected Myofibroblast Phenotype
To explore whether MMP-28 mediates TGF-β1-induced fibroblast transdifferentiation and secretion, we isolated cardiac fibroblasts from both WT and MMP-28 −/− hearts and stimulated the cells with TGF-β1. As shown in Figure  6C and 6D, α-SMA protein and mRNA expression were upregulated in the WT and MMP-28 −/− cells after stimulation with TGF-β1 (both P<0.05). This result indicates that fibroblast to myofibroblast transdifferentiation was not influenced by the deletion of MMP-28. Both fibronectin 1 and connective tissue growth factor mRNA were significantly induced with TGF-β1 stimulation in WT cells (Figure 6E and 6F; both P<0.05) . Interestingly, the upregulation of fibronectin 1, but not connective tissue 
MMP-28 Deletion Did Not Affect LV Tensile Strength at Day 3 Post-MI
Mechanical tensile strength of the infarct scar was determined in mice at day 3 post-MI, the time when ruptures are first seen and infarct tissue shows significant impairment in tensile strength. 26 Stretch ratios at rupture, expressed as the ratio of the circumferential length when the infarct tissue first breaks to the initial length, were calculated. There were no significant differences in the stretch ratios (Online Figure IIA) , suggesting that the scar stiffness at day 3 post-MI was similar between the 2 genotypes. Ultimate tensile strength multiplied by the wall thickness provided Figure IIB) . These results indicate that MMP-28 effects on rupture manifest after day 3 post-MI.
Ruptured Hearts Showed Worse LV Dilatation Than Surviving Hearts
By LaPlace law, higher LV volumes should correspond to increased LV wall stress. To explore the impact of MMP-28 deletion on LV wall stress, we measured day 3 post-MI LV volumes for all mice used for the day 7 survival study. The mice were divided into 2 groups: those that would survive 7 days and those that ruptured at days 4 to 7 post-MI. In both WT and MMP-28 −/− genotypes, the ruptured hearts showed higher end-diastolic volumes at day 3 post-MI, compared with mice that survived 7 days (Online Figure IIC; both P<0.05 ). This indicates that there was higher LV wall stress in the hearts that would go on to rupture. Of note, the end-diastolic volumes of the ruptured hearts were not different between WT and MMP-28 −/− mice, indicating that the increased LV wall stress was not sufficient to explain the increased rupture rates in MMP-28 −/− mice. These results indicate that infarct mechanics at day 3 post-MI do not explain or predict rupture at later time points.
MMP-28 Deletion Did Not Affect Regulatory T (Treg) Cell Content or Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN) Expression
To investigate the impact of MMP-28 deletion on Treg cells, we measured the mRNA expression of Foxp3 (a marker of Treg cells) in the day 7 LVIs. Foxp3 expression showed no difference between WT and MMP-28 −/− mice (Online Figure  IIIA) . PTEN is upregulated in infarct hearts and exacerbates post-MI LV remodeling by inhibition of Akt activity and IL-10 production. 36 However, PTEN expression did not show any differences (Online Figure IIIB) .
Discussion
This study evaluated the impact of MMP-28 deletion on LV remodeling and dysfunction induced by MI, focusing on inflammatory and ECM reactions. The major findings were as follows: (1) post-MI, the MMP-28 cell source switched from myocytes to macrophages; (2) MMP-28 deletion led to adverse LV remodeling and dysfunction, accompanied by increased mortality and rupture rates; (3) inflammatory factors in the infarct hearts and M2 macrophage polarization were reduced with MMP-28 deletion; (4) ECM transcription, collagen deposition and cross-linking, and myofibroblast numbers were all reduced in MMP-28 −/− mice; and (5) mechanical strength at day 3 post-MI was not different between the 2 genotypes. Taken together, these findings demonstrate that MMP-28 deficiency aggravates post-MI remodeling and dysfunction by inhibiting M2 macrophage activation, ECM synthesis, and collagen cross-linking. Importantly, this study challenges our preconceived idea that all MMPs play detrimental roles in the MI setting and should be inhibited. In the setting of MI, MMP-28 deletion had detrimental effects.
Consistent with past reports, we showed that MMP-28 is expressed by cardiomyocytes under normal conditions, suggesting a role in tissue homeostasis and turnover. 15, 16 After MI, myocytes in the infarct area undergo a dramatic loss; but MMP-28 was still robustly secreted, indicating inflammatory leukocytes could be the source. Our confocal staining confirmed that macrophages infiltrated into the infarct area served as a rich supply of MMP-28. Using a mouse model of pathogen-induced pneumonia, Manicone et al 18 found that MMP-28 was expressed by bone marrow-derived macrophages but not by alveolar macrophages. Although macrophages were the predominant source of MMP-28 in the post-MI setting, we could not exclude the possibility that other cells, such as cardiac fibroblasts, endothelial cells, and other inflammatory cells (eg, T and B lymphocytes), could express MMP-28 in the infarcted LV. Nonetheless, this is the first report to document MMP-28 in macrophages in the post-MI LV.
Post-MI, the inflammatory response initially serves to remove unwanted tissue debris, supply growth factors, and promote neovascularization and granulation tissue formation. 37 An increasing body of evidence has indicated that accentuation, prolongation, and expansion of the inflammatory reaction aggravates adverse remodeling and dysfunction after MI. 2, 32, 38, 39 However, insufficient or impaired inflammation also contributes to worsened LV remodeling. The Matsui laboratory reported that syndecan-4 deficiency amplified post-MI LV dysfunction and increased cardiac rupture, which was strongly related to defective granulation tissue formation, as evidenced by reduced numbers of leukocytes, myofibroblasts, and collagen deposition in the absence of syndecan-4. 5 Enhanced post-MI cardiac rupture could be attributed to mechanisms that impair and disorganize granulation tissue formation during the reparative phase of MI.
Likewise, a study by Nahrendorf et al 40 showed that the impaired inflammatory response promoted an increase in cardiac rupture and compromised wound healing in factor XIIIdeficient mice. Our array data revealed that MMP-28 −/− mice had lower levels of inflammatory associated factors, which, at least in part, explains the increased rupture and worse dysfunction with MMP-28 deletion. In contrast, we previously showed that MMP-28 deletion augmented the inflammatory response to accelerate cardiac aging. 15 There are 2 possible explanations for the differences seen between these 2 models (aging and MI). First, MMP-28 from different cell sources could exert distinct roles. In the aging setting, both myocytes and macrophages contribute MMP-28, but the myocyte contribution is much greater than that of the macrophage. In the post-MI setting, MMP-28 in the infarct area is mainly secreted by macrophages. Because of these differences, MMP-28 could have net roles on inflammation that are opposite. Second, depending on the different kinds of injury or stress, MMP-28 may exert differential effects on the inflammatory response. Collectively, the proper degree of inflammatory response and its timely resolution both favor stable wound repair and healing. 41 In this study, only male, but not female, MMP-28 −/− mice revealed higher rupture rates than WT counterparts. Estrogen supplementation has been shown to protect male mice from post-MI cardiac rupture by inhibiting MMP-9 activity and increasing Akt-Bcl-2 antiapoptotic signaling. 42 However, there has been no report that connects MMP-28 and estrogen to the inflammatory response.
Unexpectedly, MMP-28 deletion did not reduce macrophage numbers post-MI, indicating that the reduction in inflammatory factor levels was attributable to a differential macrophage polarization pattern rather than differences in cell infiltration. Troidl et al 43 demonstrated that macrophages are differentially activated during different phases of LV remodeling after MI. During the acute inflammatory phase, classical M1 macrophages predominate, whereas macrophages shift into an alternative anti-inflammatory M2 subtype during the scar formation and reparative period. In this study, we found that MMP-28 deletion impaired alternative M2 macrophage activation at day 7 post-MI, which could explain the increased cardiac rupture and worse remodeling observed in the MMP-28 −/− mice. Similarly, in vitro experiment confirmed that MMP-28 deletion inhibited the macrophage polarization toward M2 subtype.
Because of the limited regenerative capacity of the mammalian myocardium, a collagen-based scar is required to replace the substantial loss of cardiomyocytes, both to fill the space and maintain normal wall stress. 44 Thus, a balanced ECM turnover is of great importance to form a high-quality scar and to prevent progressive LV remodeling. 45 In this study, we found that MMP-28 deletion led to reduced mRNA transcription of ECM genes at day 7 post-MI, including Col1a1, Col3a1, and Col5a1. Our immunoblotting data confirmed the decreased protein deposition of collagen I and III in the MMP-28 −/− mice. These data indicate defective composition of the reparative scar in the absence of MMP-28. Interestingly, the absence of collagen VI attenuates LV remodeling and dysfunction post-MI, 46 suggesting different functions of individual collagen subtypes. In our study, we
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did not find any differences in collagen VI between WT and MMP-28 −/− mice. Impaired TGF-β1/Smad signaling leads to inhibited collagen synthesis and facilitates cardiac rupture post-MI. 31, 47 Our array data showed decreased TGF-β1 transcription in MMP-28 −/− mice, supporting the elevated rupture when MMP-28 is absent. Increased MMP-9 levels post-MI could contribute to cardiac rupture by degrading ECM components. 8, 10, 48, 49 Interestingly, MMP-28 −/− mice showed lower levels of MMP-9 in the plasma and LVIs, which suggests that increased cardiac rupture in MMP-28 −/− mice after MI was not MMP-9 dependent. After MI, cardiac fibroblasts differentiate into myofibroblasts, a central source of ECM. Myofibroblasts were involved in LV remodeling and repair by regulating ECM turnover. 50 Furthermore, we demonstrated that the reduced levels of ECM in MMP-28 −/− mice were a result of reduced numbers of myofibroblasts. In vitro experiments showed that MMP-28 deletion impaired fibronectin 1 expression in fibroblasts after TGF-β1 stimulation, indicating an altered myofibroblast phenotype in the absence of MMP-28.
Not only scar quantity but also quality is crucial to prevent post-MI cardiac rupture. Collagen is a relatively stiff material with high tensile strength, and small alterations in its concentration, relative proportion of different types of collagen, the diameter of collagen fibers, or their spatial alignment and cross-linking are shown to have an important effect on cardiac mechanical characteristics. 51, 52 Lysyl oxidase-mediated crosslinking of collagen I and III fibers results in the deposition of insoluble collagen fibers and increased tensile strength to resist wall stress. 33 We found that MMP-28 deletion led to reduced expression and activation of lysyl oxidase, as well as impairment in collagen cross-linking at day 7. However, mechanical testing did not show significant differences in tensile strength of day 3 infarct hearts between WT and MMP-28 −/− mice, indicating that the role of cross-linking is a late event in remodeling.
Post-MI, Treg cells infiltrate into the LVI. 53 Treg cells attenuate LV remodeling and dysfunction by suppressing leukocyte infiltration, pro-inflammatory factor secretion, apoptosis, and MMP-2 activity, as well as upregulating IL-10 expression. 53 Inhibition of PTEN has been shown to exert beneficial roles in multiple cardiac diseases, including MI, ischemia/reperfusion, and pressure overload models. 36, 54, 55 MMP-28 deletion, however, did not affect Treg cell infiltration and PTEN expression, suggesting MMP-28-mediated LV remodeling may be Treg-and PTEN-independent.
Elevated cardiac TNF-α levels facilitate MI-induced LV dysfunction. 28 In this study, TNF-α protein levels increased in the plasma, but levels were not affected by MMP-28 deletion. This indicates that differences in LV function between WT and MMP-28 −/− mice were not likely mediated through TNF-α. This study revealed a negative impact of MMP-28 deletion in the post-MI setting, indicating that MMP-28 inhibition strategies would likely be detrimental. 15, 19 Therefore, MMP-28 treatment, rather than inhibition, may protect against MIinduced LV adverse remodeling. Our data also highlight the concept that specific MMPs have much different functions post-MI, even when originating from the same cell source (eg, macrophages).
In conclusion, MMP-28 deletion aggravated post-MI LV dysfunction and rupture by blunting the inflammatory and fibrotic responses that are necessary for high-quality scar formation and proper wound healing (Online Figure IV) . Therefore, inhibiting MMP-28 and associated pathways in the post-MI setting would likely not provide a favorable approach to prevent abnormal cardiac remodeling and rupture post-MI.
